xincheng zeng

Mr. xincheng zeng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in Antibodies
Verified
Journal Article
Open access
PDF file
XZxincheng zeng
xincheng zeng
GBganggang bai
ganggang bai
CSChuance Sun
Chuance Sun
Buyong MaBuyong Ma
Buyong Ma
Recent progress in epitope prediction has shown promising results in the development of vaccines and therapeutics against various diseases. However, the overall accuracy and success rate need to be improved greatly to gain practical application significance, especially conformational epitope prediction. In this review, we examined the general features of antibody–antigen recognition, highlighting the conformation selection mechanism in flexible antibody–antigen binding. We recently highlighted the success and warning signs of antibody epitope predictions, including linear and conformation epitope predictions. While deep learning-based models gradually outperform traditional feature-based machine learning, sequence and structure features still provide insight into antibody–antigen recognition problems.

17 September 2023 in Antibodies
Verified
Journal Article
Open access
PDF file
XZxincheng zeng
xincheng zeng
TWTianqun Wang
Tianqun Wang
YKYue Kang
Yue Kang
GBganggang bai
ganggang bai
Buyong MaBuyong Ma
Buyong Ma
T cell receptor β-chain constant (TRBC) is a promising class of cancer targets consisting of two highly homologous proteins, TRBC1 and TRBC2. Developing targeted antibody therapeutics against TRBC1 or TRBC2 is expected to eradicate the malignant T cells and preserve half of the normal T cells. Recently, several antibody engineering strategies have been used to modulate the TRBC1 and TRBC2 specificity of antibodies. Here, we used molecular simulation and artificial intelligence methods to quantify the affinity difference in antibodies with various mutations for TRBC1 and TRBC2. The affinity of the existing mutants was verified by FEP calculations aided by the AI. We also performed long-time molecular dynamics simulations to reveal the dynamical antigen recognition mechanisms of the TRBC antibodies.

16 April 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
GBGanggang Bai
Ganggang Bai
XZxincheng zeng
xincheng zeng
LZLinghao Zhang
Linghao Zhang
YWYanjing Wang
Yanjing Wang
Buyong MaBuyong Ma
Buyong Ma